Posted Nov. 19, 2013 at 5:25 p.m.

Premium Lock Chelsea Therapeutics raises $21.4M in stock offering

Published: 2013-11-19 17:25:14
Updated: 2013-11-19 17:25:14

Chelsea Therapeutics logo Chelsea Therapeutics

Chelsea plans to use proceeds from the offering to fund its droxidopa drug program, including the company's work on drug candidate Northera, a compound in clinical testing to treat neurogenic orthostatic hypotension or NOH....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll